Showing results (531-540 of 541) with videos related to
Sort By:
Pageof 55
Drugs - Real World Outcomes|May 11, 2025
Switching Therapy to the Second Brand of Generic Atorvastatin: A 6-Month Retrospective Cohort, Real-World StudyPanisa Manasirisuk, Somsak Tiamkao, Chaiyasith Wongvipaporn, et al.Drugs - Real World Outcomes|April 8, 2025
Real-World Treatment Patterns Among Pediatric and Adult Patients with Crohn's Disease in the United StatesArt Kastl, Theresa Hunter Gibble, Debbie Tinsley, et al.Drugs - Real World Outcomes|April 16, 2025
Evaluation of the Association Between Postpartum Hemorrhage and Antidepressant Use: A Mendelian Randomization StudyZhenzhen Chen, Qingqing Lv, Shiteng Lin, et al.Drugs - Real World Outcomes|June 15, 2024
The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease-A Real-World StudyJames D Lewis, Theresa Hunter Gibble, Mingyang Shan, et al.Drugs - Real World Outcomes|June 5, 2024
Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin ToxicitySophia Sheikh, Taylor Munson, Gerard Garvan, et al.Drugs - Real World Outcomes|December 24, 2025
Comparison of Opioid Utilization in Older Adults with Rheumatoid Arthritis before and after Initiating Biological or Targeted Synthetic Disease-Modifying Antirheumatic DrugsYinan Huang, Shadi Bazzazzadehgan, Liang-Yuan Lin, et al.Drugs - Real World Outcomes|January 6, 2024
Evaluation of Triple Whammy Prescriptions After the Implementation of a Drug Safety AlgorithmHendrike Dahmke, Jana Schelshorn, Rico Fiumefreddo, et al.Drugs - Real World Outcomes|June 15, 2026
Treatment Patterns and Healthcare-Related Costs in Patients with Atherosclerotic Cardiovascular Disease: Insights from a Large US Healthcare InsurerJoseph L Smith, Laetitia N'Dri, Zhengzheng Jiang, et al.Drugs - Real World Outcomes|June 23, 2026
The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with CancerVeera Nurmela, Anni Juntunen, Satu Tiainen, et al.Drugs - Real World Outcomes|July 31, 2026
Real-World Effectiveness and Safety of Dotinurad in Chinese Patients with Gout: A Comparative AnalysisGuanqun Yi, Xuechan Huang, Yukai Huang, et al.Pageof 55